Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.

Authors:
Anne-Sofie Johansson
Anne-Sofie Johansson
Karolinska Institutet
Sweden
Bjorn Owe-Larsson
Bjorn Owe-Larsson
Skubiszewski Medical University
Poland
Linnea Asp
Linnea Asp
Mount Sinai School of Medicine
United States
Tomasz Kocki
Tomasz Kocki
Medical University
Ilam | Iran
Mats Adler
Mats Adler
Karolinska Institutet
Sweden
Renee Gardner
Renee Gardner
Karolinska Institutet
Sweden

J Psychiatr Res 2013 Nov 23;47(11):1815-23. Epub 2013 Aug 23.

Department of Neuroscience, Karolinska Institutet, Sweden.

Accumulating data suggest a causative link between immune stimulation, disturbed metabolism of tryptophan, and pathogenesis of bipolar disorder and schizophrenia. The goal of this study was to examine the production of kynurenic acid (KYNA), 3-hydroxykynurenine (3-HK) and the expression of kynurenine pathway enzymes involved in their synthesis and metabolism in cultured skin fibroblasts obtained from patients with bipolar disorder, schizophrenia or from healthy control individuals. The assessment was performed under basal conditions or following treatment with interferon (IFN)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, or their combinations, in cells exposed to exogenous kynurenine. In both groups of patients, the baseline production of KYNA and 3-HK was increased, as compared to control subjects. Case-treatment analyses revealed significant interactions between bipolar case status and IL-1β, IL-6, IFN-γ + TNF-α, or IFN-γ + IL-1β, as well as between schizophrenia case status and IL-1β, IFN-γ + TNF-α, or IFN-γ + IL-1β, in terms of higher 3-HK. Noteworthy, no case-treatment interactions in terms of KYNA production were found. Observed changes did not appear to correlate with the expression of genes encoding kynurenine aminotransferases (KATs), kynureninase (KYNU) or kynurenine-3-monooxygenase (KMO). The single nucleotide polymorphisms (SNPs), rs1053230 and rs2275163, in KMO influenced KYNA levels yet did not explain the case-treatment discrepancies. In conclusion, our present findings indicate the utility of skin-derived fibroblasts for kynurenines research and support the concept of kynurenine pathway alterations in bipolar disorder and schizophrenia. The increase in ratio between neurotoxic 3-HK and neuroinhibitory/neuroprotective KYNA following exposure to cytokines may account for altered neurogenesis and structural abnormalities characteristic for both diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2013.08.008DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
November 2013
13 Reads

Publication Analysis

Top Keywords

disorder schizophrenia
16
bipolar disorder
16
kynurenine pathway
12
fibroblasts patients
8
patients bipolar
8
ifn-γ il-1β
8
ifn-γ tnf-α
8
status il-1β
8
tnf-α ifn-γ
8
case status
8
il-1β il-6
8
schizophrenia
5
ifn-γ
5
il-1β
5
kyna
5
bipolar
5
well schizophrenia
4
schizophrenia case
4
il-1β ifn-γ
4
il-1β well
4

Similar Publications